4AB Stock Price, Chart, Stats & News
AbbVie Inc. (4AB) is a dividend-paying stock with a current dividend yield of 2.60% as of Jun 30, 2026. It pays 5,74 € per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 2.95% 5-year compound annual rate.
Dividend safety
4AB pays out about 100% of earnings, leaving little safety margin.
4AB chart
About
AbbVie Inc. is a global biopharmaceutical enterprise focused on the discovery, development, production, and worldwide commercialization of pharmaceutical remedies. Its diverse product portfolio targets a wide range of health conditions. Key offerings include HUMIRA, an injectable treatment for autoimmune and intestinal Behçet's diseases; SKYRIZI, indicated for moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor utilized in adults with moderate to severe active rheumatoid arthritis.
Related lists
Similar securities
Based on sector and market capitalization
